2m 2m 2m 2m 2m 2m 2m
Akebia Therapeut (AKBA)
NASDAQ
$0.96+$0.03 (+2.84%)
Price as of Jun 03, 2026 6:59 PM EDT- $273.6MMarket Cap
- -72.62%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Akebia Therapeut (AKBA)
$0.96+$0.03 (+2.84%)
AKBA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.94 | ||
Change | -$0.08 (-8.20%) | ||
Open | $1.01 | ||
High | $1.02 | ||
Low | $0.91 | ||
Previous Close | $1.02 | ||
Volume | 7,220,245 | ||
30-Day Average Volume | 5,668,652 | ||
1-Week Change | -9.96% | ||
1-Month Change | -33.11% | ||
1-Year Change | -72.62% | ||
3-Year Change | -14.87% | ||
5-Year Change | -72.21% | ||
Fundamentals | |||
Shares Outstanding | 268.3M | ||
Total Assets | $362.5M | ||
Market Cap | $273.6M | ||
Enterprise Value | $159.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$9.1M | ||
Free Cash Flow | -$21.3M | ||
EBIT | -$4.2M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $69.6M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -41 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -34 | ||
PEG | -1 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue